Eidlisz Jordan, von Simson Isabelle, Gold-von Simson Gabrielle
Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States.
Department of Medicine, State University of New York Downstate College of Medicine, Brooklyn, NY, United States.
Front Res Metr Anal. 2024 May 20;9:1376185. doi: 10.3389/frma.2024.1376185. eCollection 2024.
Technology transfer (TT) is a necessary, yet complex process to convey and disseminate scientific knowledge to the commercial sector. However, multiple barriers in TT can impede commercialization and innovative progress. To cultivate a deeper understanding, we conducted five interviews with strategic, elite leaders in different areas of TT in the United States. Experts shared their perspectives on the current state of TT, what needs improvement, and potential solutions to enhance the TT landscape, with a focus on biotechnology and medical devices. The formation of strong management teams, a comprehension of the regulatory, reimbursement, and funding pathways and policies, and thorough market assessments were noted as key aspects for venture success. Collaboration with Technology Transfer Offices (TTOs), industry experts, and strategic partners are also essential to support academic innovators and guide them throughout the complex commercialization process. There is agreement that a venture should have a defined vision and clear goals with a robust business case for the innovation; early involvement of TTOs is essential. Comprehension of the complexities and key facets of TT, while also streamlining the process, will better position biomedical innovators for success.
技术转移（TT）是一个将科学知识传递和传播到商业领域的必要但复杂的过程。然而，技术转移中的多重障碍会阻碍商业化和创新进程。为了加深理解，我们对美国技术转移不同领域的战略精英领导者进行了五次访谈。专家们分享了他们对技术转移现状、需要改进之处以及改善技术转移局面的潜在解决方案的看法，重点关注生物技术和医疗设备。强大管理团队的组建、对监管、报销和资金途径及政策的理解，以及全面的市场评估被视为创业成功的关键因素。与技术转移办公室（TTO）、行业专家和战略合作伙伴的合作对于支持学术创新者并在整个复杂的商业化过程中指导他们也至关重要。大家一致认为，创业公司应该有明确的愿景和目标，并有一个强有力的创新商业案例；技术转移办公室的早期参与至关重要。理解技术转移的复杂性和关键方面，同时简化流程，将使生物医学创新者更有成功的机会。
